Professor
Acibadem MAA University School of Medicine
Istanbul, Turkey
Mrs. Atalar has completed her undergraduate education in Iskenderun and graduated from Istanbul University, Istanbul Medical Faculty with MD degree in 1999 in Turkey. Her Radiation Oncology training was between 2000-2004 in Istanbul University, Cerrahpasa Medical Faculty, Radiation Oncology Department. During her residency she was awarded with Turkish Society of Radiation Oncology Grant in 2003 and ASCO (American Society of Clinical Oncology) Foundation International Development and Education Award (I.D.E.A) in 2004.
Between 2005-2009 she has worked as a Radiation Oncology Specialist in American Hospital Istanbul. Since 2009 she has been working in Acibadem Maslak Hospital and Acibadem MAA University Radiation Oncology Department as an Academician and full-time consultant. She has completed short-term clinical research fellowship in Stanford University, Radiation Oncology Department under guidance of Dr. John Adler and Dr. Scott Soltys in 2011 on stereotactic radiosurgery. Since 2013 she was appointed as an Associate Professor and became full professor in 2018 in Acibadem MAA University. She is a member of ASTRO, ESTRO, ASCO, RSS, IASLC, Rare Cancer Network and Turkish Radiation Oncology Society, and has served as “ASCO Resource Stratified International Guideline Advisory Group Member” between December 2013 to June 2018.
She has been awarded from IASLC with "International Mentorship Award" in September 2018.
Today, Dr. Atalar is the Vice president and President Elect of Turkish Radiation Oncology Society and she has been elected as the new Chair of ESTRO National Societies Committee and will be in charge between May 2024-May 2027. She is currently acting as the Organizing Committee Member of RSS 2023.
Her main field of interest is Stereotactic Radiosurgery, mainly on Central nerve system tumors, Thoracic tumors, and Gastrointestinal cancers. Other than these she is a consultant for advanced techniques such as MR guided and CT guided adaptive stereotactic radiotherapy.
Disclosure information not submitted.
EMPOWERING EXCELLENCE: CELEBRATING THE ACHIEVEMENTS OF WOMEN IN RADIATION ONCOLOGY
Thursday, March 20, 2025
6:30 PM – 7:15 PM MST
Showdown Debate I | AI IS READY FOR CLINICAL DECISION SUPPORT
Friday, March 21, 2025
8:00 AM – 9:00 AM MST